Reports
The state of healthcare marketing and compliance, measured every quarter
Two forces now decide who wins patients in regulated healthcare: how the FDA and FTC enforce marketing rules, and how Google and AI assistants route people to care. We measure both, across every vertical we serve and one report at a time. Each hub below always opens the latest edition.
Flagship · latest Q2 2026
Healthcare Marketing and Compliance Report
The cross-vertical flagship. FDA and FTC enforcement trends alongside search demand and AI-assistant visibility across every regulated healthcare vertical we track.
Open the report →By vertical
GLP-1 and Weight Loss Marketing Report
The gold rush and the crackdown. Where GLP-1 and weight-loss demand is going, how enforcement is tightening, and which brands own the AI answers.
TRT and Hormone Marketing Report
Hormone optimization sits next to a grey market of SARMs and compounded products. Where demand is, where the enforcement edge is, and who wins AI answers.
Medical Spa and Aesthetics Marketing Report
The most local game in aesthetics. Where med-spa demand concentrates, how product-linked claims draw letters, and how much local ground is still open.
Peptide Marketing Report
The sharpest enforcement edge in the field. Peptides live in an FDA grey zone of 503A and 503B compounding and research-use-only marketing.
Every edition is drawn from the Authoritize Atlas, our corpus of FDA and FTC actions, and from live search and AI-citation measurement. Screen your own copy against the same rules with the free Claim Checker.